iGan Partners
VC Fund
Toronto, Canada
iGan Partners is a VC fund in Toronto focused on Health Care and Software. iGan Partners, along with its sister fund Rowanwood Ventures, invests in emerging tech companies. With a focus on Digital Health and B2B SaaS, we invest in dynamic management teams, empowering them to build impactful businesses. We have built large successful companies and understand the challenges facing growing businesses, having faced themourselves. We provide early stage companies with smart capital, a unique active management approach and exclusive access to a network of industry partners and sector specific co-investors to help them succeed.
- Total investments:
- 49
- Last investment:
- Lead investor:
- 45%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries iGan Partners invests in
Stages iGan Partners invests in
Countries iGan Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.9M–$5M
- Series A
- $4M–$17M
- Venture - Series Unknown
- $10M–$14M
Investment Focus
Industry
- Health Care 19 (39%)
- Software 11 (22%)
- Medical 9 (18%)
- Medical Device 5 (10%)
- Information Technology 5 (10%)
Stage
- Seed 20 (41%)
- Series A 8 (16%)
- Venture - Series Unknown 6 (12%)
- Funding Round 4 (8%)
- Pre-Seed 3 (6%)
Country
- Canada 24 (49%)
- United States 4 (8%)
- Israel 1 (2%)
- United Kingdom 1 (2%)
- United Arab Emirates 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Joel Finlayson
Partner
|
Partner | Total investments: 1 | Find email | |
Anand Ganeshalingam
Analyst
|
Analyst | Total investments: 0 | Find email | |
Billy Lai
Analyst
|
Analyst | Total investments: 0 | Find email | |
Claudia Jimenez
Business Operations Manager
|
Business Operations Manager | Total investments: 0 | Find email | |
Grace Pedota
Marketing Director
|
Marketing Director | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Adenocyte
|
Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor. | $10M / Venture - Series Unknown / May 26, 2026 | |
Exact Imaging
|
Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging. | $10M / Venture - Series Unknown / Feb 10, 2026 | |
Docsi
|
Docsi is a software company that offers a unique solution to bridge the communication gap between surgeons and administrators. Their main product, the DOCSI Dashboard, provides preference card insights, making it easier for healthcare professionals to access and manage their accounts. The dashboard is designed to optimize preference card usage,ensuring that surgeons have what they need when they need it. This innovative approach to healthcare communication aims to improve efficiency and streamline processes within the medical field. | Venture - Series Unknown / Aug 07, 2025 | |
Cosm Medical
|
Cosm Medical is a VC-backed health-tech startup building and commercializing a software-enabled medical device platform to improve the lives of women affected by pelvic floor disorders. | Seed / Jun 05, 2025 | |
Cyborg
|
We develop Cyborg Cloud Search, the world's first encrypted search for the cloud. | Venture - Series Unknown / May 29, 2025 | |
Segmed
|
Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $10.4M / Series A / Sep 03, 2024 | |
MolecuLight
|
Moleculight is developing a non-invasive optical technology that acquires images in a manner similar to standard point-and-shoot digital cameras.The device provides real-time bacteriological information which is otherwise unobtainable using industry standard wound assessment techniques, including conventional white light visualization.Thefirst application of this technology will be in the global wound care market where there is an urgent medical need and where MolecuLight can significantly improve outcomes by providing rapid and accurate diagnosis. | $8.5M / Series C / Aug 15, 2024 | |
RetiSpec
|
RetiSpec is developing a non-invasive eye scanner for early detection of Alzheimer’s Disease pathology years before symptoms occur, so that clinicians can intervene with emerging therapeutics early, when there’s a chance of actually impacting the disease. | $10M / Series A / Jul 26, 2024 | |
Flosonics
|
Flosonics is a medical device company that focuses on developing non-invasive sensors to improve the management of critically ill patients. Flosonics's flagship smart-bandage product, the FloPatch, addresses unmet clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance,emergency department, operating room, and intensive care unit. | $20M / Series C / Mar 19, 2024 | |
|
Segmed
|
Segmed offers extensive clinical data and diagnostic-grade medical images to support life sciences and technology industries. The company facilitates rapid discovery and development of predictive models, improving patient recruitment and data management. Its solutions cater to pharmaceutical and medical device sectors, enhancing research andregulatory processes. | $5.2M / Seed / Nov 14, 2022 | |
| See all 49 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does iGan Partners invest in?
iGan Partners invests primarily in Health Care, Software and Medical startups, most often at Seed and Series A stage. Most of the 49 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is iGan Partners's check size?
iGan Partners typically joins rounds of $1.9M–$5M at Seed, $4M–$17M at Series A and $10M–$14M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds iGan Partners participates in.
How do I contact iGan Partners?
Public channels for iGan Partners include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at iGan Partners?
The team at iGan Partners includes Joel Finlayson (Partner), Anand Ganeshalingam (Analyst) and Billy Lai (Analyst), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
